Mostrar el registro sencillo del ítem

dc.contributor.authorLópez Pérez, David 
dc.contributor.authorRedruello Romero, Anais 
dc.contributor.authorGarcía Rubio, Jesús 
dc.contributor.authorArana, Carlos
dc.contributor.authorGarcía Escudero, Luis A.
dc.contributor.authorTamayo, Francisco
dc.contributor.authorPuentes Pardo, José David 
dc.contributor.authorMoreno San Juan, Sara
dc.contributor.authorSalmerón Escobar, Francisco Javier 
dc.contributor.authorBlanco Morón, Armando 
dc.contributor.authorGálvez Peralta, Julio Juan 
dc.contributor.authorLeón López, Josefa
dc.contributor.authorCarazo Gallego, Ángel
dc.date.accessioned2021-06-23T11:23:26Z
dc.date.available2021-06-23T11:23:26Z
dc.date.issued2021-05-21
dc.identifier.citationLopez-Perez D... [et al.] (2021) In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes. Front. Immunol. 12:664576. doi: [10.3389/fimmu.2021.664576]es_ES
dc.identifier.urihttp://hdl.handle.net/10481/69363
dc.descriptionThis work was supported by Instituto de Salud Carlos III (grant PI15/01361), Spain; and MINECO (grant DPI2017-84439-R), Madrid and FEDER. DL-P is a predoctoral fellow ("Programa de doctorado en Bioquimica y Biologia Molecular", B16.56.1) funded by the Spanish Ministry of Science and Innovation (" Formacion de profesorado universitario" grant FPU18/ 04432). DL-P participated in this work thanks to a grant from University of Granada ("Becas de iniciacion a la investigacion del plan propio de la UGR").es_ES
dc.description.abstractType 2 diabetes (T2D) is a rising global health problem mainly caused by obesity and a sedentary lifestyle. In healthy individuals, white adipose tissue (WAT) has a relevant homeostatic role in glucose metabolism, energy storage, and endocrine signaling. Mast cells contribute to these functions promoting WAT angiogenesis and adipogenesis. In patients with T2D, inflammation dramatically impacts WAT functioning, which results in the recruitment of several leukocytes, including monocytes, that enhance this inflammation. Accordingly, the macrophages population rises as the WAT inflammation increases during the T2D status worsening. Since mast cell progenitors cannot arrive at WAT, the amount of WAT mast cells depends on how the new microenvironment affects progenitor and differentiated mast cells. Here, we employed a flow cytometry-based approach to analyze the number of mast cells from omental white adipose tissue (o-WAT) and subcutaneous white adipose tissue (s-WAT) in a cohort of 100 patients with obesity. Additionally, we measured the number of mast cell progenitors in a subcohort of 15 patients. The cohort was divided in three groups: non-T2D, pre-T2D, and T2D. Importantly, patients with T2D have a mild condition (HbA1c <7%). The number of mast cells and mast cell progenitors was lower in patients with T2D in both o-WAT and s-WAT in comparison to subjects from the pre-T2D and non-T2D groups. In the case of mast cells in o-WAT, there were statistically significant differences between non-T2D and T2D groups (p = 0.0031), together with pre-T2D and T2D groups (p=0.0097). However, in s-WAT, the differences are only between non-T2D and T2D groups (p=0.047). These differences have been obtained with patients with a mild T2D condition. Therefore, little changes in T2D status have a huge impact on the number of mast cells in WAT, especially in o-WAT. Due to the importance of mast cells in WAT physiology, their decrease can reduce the capacity of WAT, especially o-WAT, to store lipids and cause hypoxic cell deaths that will trigger inflammation.es_ES
dc.description.sponsorshipInstituto de Salud Carlos III PI15/01361es_ES
dc.description.sponsorshipMINECO, Madrid DPI2017-84439-Res_ES
dc.description.sponsorshipEuropean Commissiones_ES
dc.description.sponsorshipSpanish Ministry of Science and Innovation (" Formacion de profesorado universitario" grant) FPU18/04432 B16.56.1es_ES
dc.description.sponsorshipUniversity of Granada ("Becas de iniciacion a la investigacion del plan propio de la UGR")es_ES
dc.language.isoenges_ES
dc.publisherFrontiers Research Foundationes_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectMast celles_ES
dc.subjectT2Des_ES
dc.subjectAdipose tissuees_ES
dc.subjectObesity es_ES
dc.subjectFlow cytometry es_ES
dc.subjectAngiogenesises_ES
dc.subjectInflammation es_ES
dc.subjectAdipogenesises_ES
dc.titleIn Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabeteses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.3389/fimmu.2021.664576
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 3.0 España